Optimizing Regulatory Review Processes with Pinnacle 21 Enterprise

This case study outlines the implementation of Pinnacle 21 Enterprise by Zhejiang Longcharm Biomedical Technology to enhance their regulatory review processes for non-clinical and clinical research. The document details the challenges faced by Longcharm, including the inefficiencies of manual data review and the need for improved communication with clients. The adoption of Pinnacle 21 Enterprise has facilitated a collaborative environment, allowing for real-time access to critical documents and reducing the risk of data rejection by regulatory agencies. The case study highlights the benefits of using standardized formats, such as CDISC, which streamline data submission and improve overall data quality. Additionally, it discusses the onboarding process and training provided by Certara, emphasizing the thoroughness of the training that enabled Longcharm to effectively utilize the software. The integration of P21E with other tools is also mentioned, showcasing its role in accelerating product launches and enhancing the quality of submissions to regulatory bodies.